Beste COR2ED podcasts (2024)

1
Diagnosis and management of short stature patients 33:58

5M ago33:58

33:58

Do you know how to differentiate between growth hormone deficiency (or GHD) and primary IGF-I deficiency (or growth hormone resistance) and the key challenges in the diagnosis and management of patients with short stature conditions? For children presenting with short stature, an early and correct diagnosis is essential to allow children to achieve…

1
Gene therapy and gene-modified cell therapy in rare diseases 27:39

5M ago27:39

27:39

Gene therapy and gene-modified cell therapies have a great potential for rare diseases to either help patients to cure their disease or improve their lives. Did you know that gene therapy will probably become a major treatment option for many rare diseases in the near future? Listen as expert hematologists delve into this topic and take hemophilia …

1
Perioperative Thromboprophylaxis Revisited 19:16

5M ago19:16

19:16

Thrombotic risk is a constant threat in perioperative patients, but it has decreased with the evolution of surgical technology. Do you know how to minimise the risk of thrombosis in your surgical patients? Learn from expert colleagues from the University of Basel, Switzerland: Prof. Dimitrios Tsakiris (hematologist) and Prof. Daniel Bolliger (anest…

1
Prostate Cancer: Pre-Analytical Phase Challenges and Biomarker Testing 29:54

5M ago29:54

29:54

What are the common pre-analytical phase challenges in prostate cancer, and how can we overcome them? Why is it important to identify genetic alterations? You are listening to part 1 of a 3-part video podcast series moderated by active, practising oncologists/hematologists, the Oncology Brothers, Drs. Rohit and Rahul Gosain. In this episode, you’ll…

1
VTE: how long should anti-thrombotic treatment be? 25:38

6M ago25:38

25:38

COR2ED Medical Education: Extended anticoagulation beyond the initial 3 months is indicated for all types of VTE, except in surgery-or trauma-VTE or in patients at high risk of bleeding. Are you up to date on the latest treatment options for VTE and their duration? Expert haematologists Prof. Dimitrios Tsakiris (University of Basel, Switzerland) an…

1
Treatment of severe PPH – Learnings from clinical practice 23:31

6M ago23:31

23:31

COR2ED Medical Education: In this podcast, Prof. Andra H. James (Professor Emeritus of Obstetrics and Gynecology, Division Maternal Fetal Medicine, Duke University Hospital, Durham, North Carolina, US) and Dr Maria Elisa Mancuso (Senior Haematology Consultant at the Center for Thrombosis and Hemorrhagic Diseases of IRCCS Humanitas Research Hospital…

1
IUD Placement: How to Reduce Anxiety and Pain for Patients 35:29

6M ago35:29

35:29

COR2ED Medical Education: Welcome to the "Addressing Anxiety and Pain Around IUD Placement" podcast, where experts in the field, Carolyn Westhoff MD, Michal Yaron MD, and Patty Cason RN, MS, FNP-BC, delve into the world of intrauterine contraception. These seasoned clinicians share their vast experience in providing IUD placements, training others,…

1
Cancer and Thrombosis 27:20

7M ago27:20

27:20

COR2ED Medical Education: In this podcast episode, Prof Dimitrios Tsakiris (Haematologist, Basel University, Switzerland) and Dr Lars Asmis (Haematologist, University of Zurich, Switzerland) discuss the association between thrombosis and cancer. Experts discuss how different tumours affect the risk for thrombosis in patients and genetic disorders s…

1
Severe PPH – Definitions and Real-World Incidence 25:45

7M ago25:45

25:45

COR2ED Medical Education: Dr Homa K. Ahmadzia (Maternal-Fetal Medicine specialist and Assistant Professor in the Department of Obstetrics and Gynecology at George Washington University hospital, USA) and Dr Jarmila A. Zdanowicz (Senior Consultant in Obstetrics and Gynecology, Clinical Head Maternity Unit, Fellow in Feto-Maternal Medicine, Departmen…

1
Advanced HCC: 2nd line treatment selection and the right time to switch 29:25

8M ago29:25

29:25

COR2ED Medical Education: Prof. Dr Amit Singal, Gastroenterologist and Hepatologist at UT Southwestern Medical Center, USA and Prof. Dr Jeroen Dekervel, GI Oncologist at UZ Leuven, Belgium, discuss the new era in treating patients with advanced HCC, focusing on treatment selection and the right time to switch to 2nd line therapy. In this podcast, t…

1
Breast Cancer: Oral SERDs in ER+ breast cancer. Episode 3 - rare cases & treatment challenges 26:17

8M ago26:17

26:17

COR2ED Medical Education: In this final episode, the experts discuss two patient case studies with oral SERDs (oral selective estrogen receptor degraders) and a novel therapy for ER+/HER2- advanced or metastatic breast cancer. Each patient presents unique and rare situations that shed light on the challenges confronting healthcare professionals and…

1
Monitoring anticoagulation: yes or no? 20:58

8M ago20:58

20:58

COR2ED Medical Education: In this podcast episode, Prof Dimitrios Tsakiris (Haematologist, Basel University, Switzerland) and Assoc. Prof. Michael Nagler (Haematologist, Inselspital University Hospital, Bern, Switzerland) discuss when to monitor anticoagulation in clinical practice, covering both the technical aspects and the clinical usefulness. T…

1
An introduction to molecular testing: what and when across the patient journey 24:55

9M ago24:55

24:55

COR2ED Medical Education: This podcast episode provides an introduction to molecular testing in the diagnosis and treatment of cancer. Prof. David Hong from MD Anderson Cancer Center, Houston, Texas, USA and Dr Tracy Stockley from the University Health Network, Toronto, Canada discuss optimal testing strategies to identify actionable mutations. The…

1
Breast Cancer: Oral SERDs in ER+ breast cancer. Episode 2 - treatment selection and beyond 25:27

9M ago25:27

25:27

COR2ED Medical Education: In this podcast, the experts deep-dive into two patient case studies of ER+/HER2- metastatic breast cancer, discussing the intricacies of treatment selection and sequencing to maximise outcomes, current data, and what to consider when adjusting dosage or switching treatments. Dr. Rena Callahan an Associate Clinical Profess…

1
Metastatic gastric and GEJ cancers: clinical case discussions ep.2 16:16

9M ago16:16

16:16

COR2ED Medical Education: This podcast series consists of two episodes where expert oncologists Dr Sam Klempner (Massachusetts General Hospital, USA) and Dr Lizzy Smyth (Oxford University Hospitals NHS Foundation Trust, UK) discuss patient cases focusing on gastric and gastroesophageal junction cancer. In the second episode, Dr Klempner presents a …

1
Non-metastatic gastric and GEJ cancers: clinical case discussions ep.1 27:27

9M ago27:27

27:27

COR2ED Medical Education: This podcast series consists of two episodes where expert oncologists Dr Sam Klempner (Massachusetts General Hospital, USA) and Dr Lizzy Smyth (Oxford University Hospitals NHS Foundation Trust, UK) discuss patient cases focusing on gastric and gastroesophageal junction cancer. In this first episode, Dr Smyth presents a cas…

1
PBC Highlights from EASL 2023 – episode 2 22:50

10M ago22:50

22:50

COR2ED Medical Education: Robert Mitchell-Thain, CEO of the PBC Foundation, Edinburgh, UK and Kath Houghton, Autoimmune Specialist Nurse, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK, discuss their ‘Primary Biliary Cholangitis (PBC) highlights from EASL 2023’ in this podcast. Their discussion covers the relationship between ini…

1
PBC Highlights from EASL 2023: Episode 1 30:45

10M ago30:45

30:45

COR2ED Medical Education: Prof. Gideon Hirschfield, Professor of Medicine, Division of Gastroenterology, University of Toronto, Canada and Dr Emma Culver, Consultant Hepatologist and Honorary Senior Lecturer at the John Radcliffe Hospital and University of Oxford, UK discuss their ‘Primary Biliary Cholangitis (PBC) highlights from EASL 2023’ in thi…

1
Breast Cancer : Oral SERDs in ER+ breast cancer. Episode 1 - efficacy and safety and treatment landscape 23:12

10M ago23:12

23:12

COR2ED Medical Education: In this podcast, the experts give an overview of the EMERALD trial and present elacestrant as the first, and currently only, oral SERD to be FDA approved. They focus on the efficacy results and landmark analysis not only according to the duration of CDK4/6i prior treatment but also to the presence/absence of ESR1 mutation.…

1
Treatment Intensification in mCSPC - The Nurse Perspective 19:44

10M ago19:44

19:44

COR2ED Medical Education: In this podcast GU NURSES CONNECT members Brenda Martone and Jennifer Sutton discuss the nurse role in managing treatment intensification for metastatic castration sensitive prostate cancer(mCSPC) patients with triplet therapy of ADT + docetaxel + a novel hormonal agent (NHA). They focus on patient selection, AE management…

1
Treatment sequencing in advanced mCRC patients 21:09

12M ago21:09

21:09

COR2ED Medical Education: This podcast episode discusses treatment sequencing in advanced metastatic colorectal cancer (mCRC) patients, third line and beyond. Dr Shubham Pant from MD Anderson Cancer Center, Houston Texas USA and Dr Jenny Seligmann from the University of Leeds, UK discuss treatment considerations in these patients and evaluate recen…

1
Case-based discussion on which mCSPC patients benefit from early treatment intensification 22:48

1y ago22:48

22:48

COR2ED Medical Education: Assoc. Prof. Shilpa Gupta and Dr Fabio Schutz, discuss early treatment intensification with triplet therapy for metastatic castration-sensitive prostate cancer (mCSPC) in this GU CONNECT podcast. The experts discuss how to apply key data from the PEACE 1 and ARASENS trials of triplet therapy with abirateroneand darolutamid…

1
Overview of efficacy and safety data of combination therapy with PARPi and NHAs 22:49

1y ago22:49

22:49

Overview of efficacy and safety data of combination therapy with PARPi and NHAs, incorporating the latest data presented and the impact for the treatment of patients with mCRPC COR2ED Medical Education: Dr Tanya Dorff, a Medical Oncologist from the City of Hope Comprehensive Cancer Center and Dr Neeraj Agarwal, Medical Oncologist and Director of th…

1
Advanced HCC and not eligible for IO – what are the treatment options? 24:54

1y ago24:54

24:54

COR2ED Medical Education: Prof. Dr James Harding, Medical Oncologist at Memorial Sloan Kettering Cancer Center and Prof. Dr Sammy Saab, Gastroenterologist and Transplant Hepatologist at the David Geffen School of Medicine, both from the USA, discuss the treatment options for advanced hepatocellular carcinoma (HCC) patients who are not eligible for …

1
PARPi and NHA combination therapy for patients with mCRPC – a US and EU perspective 19:43

1y ago19:43

19:43

COR2ED Medical Education: Dr Neal Shore, Uro-Oncologist and Chief Medical Officer for Genesis Care and Urology and Surgical Oncology in the United States and Dr Elena Castro, Medical Oncologist at Hospital Universitario 12 de Octubre in Madrid, discuss clinical implementation of PARP inhibitors and novel hormonal agent (NHA) combinationtherapy for …

1
Clinical implementation of PARPi monotherapy for prostate cancer patients – a US and EU perspective 21:50

1y ago21:50

21:50

COR2ED Medical Education: Dr Neal Shore, Uro-Oncologist and Chief Medical Officer for Genesis Care and Urology and Surgical Oncology in the United States and Dr Elena Castro, Medical Oncologist at Hospital Universitario 12 de Octubre in Madrid, discuss clinical implementation of PARP inhibitor monotherapy for prostate cancer patients, providing bot…

1
The nurses’ perspective: Systemic therapy in endometrial carcinoma 28:03

1y ago28:03

28:03

Medical education: Join Lead Nurse Andreia Fernandes and Clinical Nurse Specialist Jo Pearson as they explain how to help patients navigate the side effects of systemic therapies in endometrial carcinoma. Specialist nurses have a critical role helping women stay on treatment and at home for as long as possible. They discuss their privileged positio…

1
The physicians’ perspective: Systemic therapy in endometrial carcinoma 29:25

1y ago29:25

29:25

Medical education: Join world-renowned gynaecological oncology experts Dr Domenica “Ketta” Lorusso and Dr Mansoor Mirza as they explore the changing landscape of systemic treatment in endometrial carcinoma. Single-agent immunotherapies (pembrolizumab and dostarlimab), and now immunotherapy and antiangiogenic therapy combinations (pembrolizumab and …

1
Update from ASCO GI 2023 Ep 2: lower GI cancer highlights 24:10

1y ago24:10

24:10

COR2ED Medical Education: This episode, covers the highlights on colorectal cancer from ASCO GI 2023. Prof. Andrea Sartore-Bianchi (Niguada Cancer Center, Milan, Italy) and Prof. Shubham Pant (MD Anderson Cancer Center, Houston, TX, USA) discuss a number of key abstracts from the meeting and their implications for clinical practice. The experts sta…

1
Update from ASCO GI 2023: upper GI cancer highlights 25:18

1y ago25:18

25:18

COR2ED Medical Education: This episode, covers the highlights on gastroesophageal, gastric and gastroesophageal junction (GEJ) cancer from ASCO GI 2023. Dr Nataliya Uboha (University of Wisconsin, USA) and Dr Efrat Dotan(Fox Chase Cancer Center, USA) discuss a number of key abstracts from the meeting and their implications for clinical practice. Th…

1
Gynaecological considerations in Women with Bleeding Disorders 19:18

1+ y ago19:18

19:18

COR2ED Medical Education: In this podcast, Dr Sarah O’Brien and Dr Homa Ahmadzia discuss gynaecological considerations in women and girls who have an underlying bleeding disorder. The experts discuss the two sides of the coin regarding women with bleeding disorders: women may have uterine bleeding due to their bleeding disorder, however there can a…

1
SARCOMA updates from CTOS 2022 22:24

1+ y ago22:24

22:24

COR2ED Medical Education: In this podcast, Prof. Jonathan Trent and Prof. Robin Jones discuss what’s new in the patient management in sarcoma from CTOS 2022. The Connective Tissue Oncology Society is an international group of physicians and scientists with a primary interest in the tumours of connective tissues. With nearly 600 attendees, 10 sessio…

1
Clinical implementation of targeted and immunotherapies for advanced RCC 19:51

1+ y ago19:51

19:51

Prof. Thomas Powles, a Medical Oncologist from Barts Cancer Centre in the UK and Dr Friederike Schlürmann a Medical Oncologist from University Hospital of Brest and Quimper in France, discuss the clinical implementation of targeted and immunotherapies for advanced renal cell carcinoma (RCC). In this podcast, the two experts discuss data from key tr…

1
Why iron matters in women with bleeding disorders 22:02

1+ y ago22:02

22:02

COR2ED Medical Education: In this podcast, Haematologists Dr Michelle Lavin and Dr Roseline d’Oiron discuss the importance of recognising and correcting iron deficiency in women and girls with bleeding disorders. Iron deficiency occurs very frequently in this population, but challenges with definitions, lab tests and reference ranges can make it ha…

1
The role of SSA at progression – to continue or not? 32:39

1+ y ago32:39

32:39

COR2ED Medical Education: In this podcast, Prof. Martyn Caplin and Dr Aman Chauhan discuss the role of somatostatin analogues (SSAs) at progression and whether to continue or not. In patients with well-differentiated Grade 1/2 neuroendocrine tumours (NETs) and slowly progressive asymptomatic disease, potential strategies for continuing SSA at progr…

1
Treating von Willebrand Disease: Does the Type Matter? 21:45

1+ y ago21:45

21:45

COR2ED Medical Education: Haematologists Prof. Ana Boban and Dr Jonathan Roberts discuss how the type of von Willebrand disease (VWD) impacts the treatment. In this podcast, aimed at healthcare professionals outside of haematology, the experts summarise the key treatment options for VWD and discuss how they make treatment decisions on a daily basis…

1
HCC updates from ILCA and ESMO congressess 2022 30:22

1+ y ago30:22

30:22

COR2ED Medical Education: In this HCC CONNECT podcast HCC Experts Prof. Matthias Pinter and Prof. Jeroen Dekervel, discuss and debate the clinical implications of new HCC Phase 3 clinical trials data presented and discussed at the ILCA and ESMO congresses. They discuss Immuno-oncology agents and their place in the upcoming updated guidance such as …

1
GI CONNECT Update from ESMO 2022 Ep 2: upper GI cancer highlights 21:28

1+ y ago21:28

21:28

COR2ED Medical Education: This second GI CONNECT podcast episode, covers the highlights on gastroesophageal cancer from ESMO 2022. Dr Sam Klempner (Massachusetts General Hospital, Boston, USA) and Dr Yelena Janjigian (Memorial Sloan Kettering Cancer Center, New York, USA) discuss a number of key posters and oral presentations from the meeting and t…

1
GI CONNECT Update from ESMO 2022 Ep 1: lower GI cancer highlights 23:43

1+ y ago23:43

23:43

COR2ED Medical Education: In the first episode of this GI CONNECT podcast covering the lower gastrointestinal (GI) cancer highlights from ESMO 2022, Dr Jenny Seligmann, Medical Oncologist from the University of Leeds in the UK and Dr Dominik Modest, Medical Oncologist from the Charité Universitaetsmedizin, Berlin, Germany discuss a number of key or…

1
ASBMR 2022 Rare Bone Disease Highlights: Episode 3 23:01

1+ y ago23:01

23:01

In this third episode of a three-episode podcast series, COR2ED and ASBMR have partnered with patient advocates Inês Alves (European Rare Bone Forum) and Tracy Hart (Osteogenesis Imperfecta Foundation) to provide rare bone disease highlights from the ASBMR 2022 Annual Meeting, focusing on the patient perspective. The experts opened the podcast with…

1
ASBMR 2022 Rare Bone Disease Highlights: Episode 2 15:17

1+ y ago15:17

15:17

In this second episode of a three-episode podcast series, COR2ED and ASBMR have partnered with Professor Eric Rush (Children’s Mercy Hospital) to provide rare bone disease highlights from ASBMR 2022 Annual Meeting. Prof. Rush opens with detailed information on fibrodysplasia ossificans progressiva (FOP): symptoms of this severe congenital condition…

1
ASBMR 2022 Rare Bone Disease Highlights: Episode 1 16:37

1+ y ago16:37

16:37

In this first episode of a three-episode podcast series, COR2ED and ASBMR have partnered with Professor Anna Teti (University of L’Aquila) to provide rare bone disease highlights from the Rare Diseases Symposium that preceded the ASBMR 2022 Annual Meeting. Opening with an overview of ongoing clinical research in several rare bone diseases, Prof. Te…

1
What to Expect When They’re Expecting: Bleeding Disorders and Pregnancy 25:31

1+ y ago25:31

25:31

COR2ED Medical Education: In this podcast, Obstetrician and Gynaecologist Prof. Rezan Abdul-Kadir and Advanced Nurse Practicioner Debra Pollard discuss the impact of bleeding disorders before, during and after pregnancy and delivery. Their share their views on what healthcare providers should take into consideration when a woman with a bleeding dis…

1
Flexible Dosing of Oral Treatments in mCRC 22:19

1+ y ago22:19

22:19

COR2ED Medical Education: In this podcast, Sven De Keersmaecker, RN and Assoc. Prof. Gerald Prager, MD discuss flexible dosing regimens of the oral treatments regorafenib, trifluridine / tipiracil (TAS-102) and capecitabine to optimise treatment duration and to manage adverse events in patients with metastatic colorectal cancer. The two experts als…

1
Clinical Implications: updated Bone Sarcoma guidelines 27:14

1+ y ago27:14

27:14

COR2ED Medical Education: In this SARCOMA CONNECT Guidelines Podcast, two SARCOMA CONNECT Experts, Prof. Robert Maki and Prof. Silvia Stacchiotti, discuss recent updates in the ESMO and NCCN bone sarcoma guidelines. Focussing on osteosarcoma and Ewing sarcoma, but also including chordoma and Giant Cell Tumour of bone, the Experts compare and contra…

1
Role of immunotherapy beyond advanced HCC 29:42

1+ y ago29:42

29:42

COR2ED Medical Education: In this podcast, liver cancer experts Prof. Amit Singal and Assoc. Prof Neil Mehta discuss recent advances in systemic and locoregional therapy for advanced and early stage hepatocellular carcinoma (HCC). They focus on the role of immunotherapy and review data from three major congresses in 2022 (ASCO, WCGIC and ILC) toget…

1
Changing paradigms of haemophilia care in Europe 24:06

1+ y ago24:06

24:06

Changing paradigms of haemophilia care in Europe COR2ED Medical Education: In this podcast, Prof. Cedric Hermans and Prof. Jerzy Windyga discuss their perspectives on the changing paradigms of haemophilia care. They share their past experience and their views on the current situation in Europe, based on results from a recent survey and published in…

1
Prostate Cancer Highlights from ASCO GU, ASCO and EAUN 2022 22:00

1+ y ago22:00

22:00

Prostate Cancer Highlights from ASCO GU, ASCO and EAUN 2022 COR2ED Medical Education: In this podcast Dr Jason Alcorn and Jennifer Sutton discuss the oncology nursing highlights from ASCO GU, ASCO and EAUN 2022. The experts discuss: Treatment intensification with triplet therapy for mCSPC patients with practice changing data from the ARASENS trial …

Podcasts die het beluisteren waard zijn

COR2ED Podcasts

Podcasts die het beluisteren waard zijn

Korte handleiding